Overall, that's a pretty damn good quarter given the uncertain healthcare environment and weak hospital budgets. By contrast, St. Jude had a bad miss. This bolds well for when hospitals are back up to full strength.
I would still like a stock buyback program put in place given how poorly the stock has done, especially recently. Hope some research houses re-iterate their BUY recommendations.
just to be clear: I own VOLC stock have for some time but I refuse to wear the rose-colored glasses
I've been able to judiciously sell covered calls that have always expired most recently the jan 17.50s for 1.25 a few weeks ago (looks like those are safe) so I've been able to reduce my cost basis to where I am comfortable holding
but I would not advise anyone else to buy VOLC right now